arrow
I

Iveta Selingerová

clinical trials
H指数:12
被引数:535

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial

实体肿瘤患者接受BNT162b2 COVID-19疫苗基础免疫后,主动治疗情况下SARS-CoV-2特异性体液和细胞免疫应答模式:CoVigi IV期试验结果

2025-05-170
OA
A 11C-METHIONIN PET FOR RADIOTHERAPY TREATMENT PLANNING IN PATIENTS WITH RAPID EARLY PROGRESSION AFTER GLIOBLASTOMA SURGERY: PROSPECTIVE PHASE II TRIAL

11c-蛋氨酸PET用于胶质母细胞瘤手术后快速早期进展的患者的放射治疗计划: 前瞻性II期试验

2024-10-170
PRE
11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)
2024-06-154
OAAI
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice
2024-01-080
OAAI
11C-METHIONIN PET FOR RADIOTHERAPY TREATMENT PLANNING IN PATIENTS WITH RAPID EARLY PROGRESSION AFTER GLIOBLASTOMA SURGERY: PROSPECTIVE PHASE II TRIAL

11c-蛋氨酸PET用于胶质母细胞瘤手术后快速早期进展的患者的放射治疗计划: 前瞻性II期试验

2023-09-080
PRE